AWARENESS OF RISK FACTORS OF HEPATITIS B AND C AMONG PEOPLE
Main Article Content
Keywords
Awareness, Hepatitis A, Hepatitis B
Abstract
Background: Viral hepatitis exists throughout the world and is a major global public health problem affecting millions of people. Hepatitis B (HBV) and hepatitis C (HCV) virus are the commonest causes of inflammation of the liver leading to chronic liver diseases. According to WHO criteria an estimated 240 million people are chronically affected with hepatitis B.
Objective: Our objective is to assess the current level of knowledge regarding the risk factors of hepatitis among the patients coming to tertiary care hospital.
Study Design: Cross-sectional survey from OPD of Shalamar hospital Lahore Punjab Pakistan.
Setting: A cross sectional study was conducted among the patient presented to the OPD Of Shalamar hospital. Total 150 patients aged 17-72 years over the period of 2 months (June-July) were considered for inclusion.
Results: To find out the percentage of awareness of risk factors of hepatitis B and c in 150 patients of OPD room of Shalamar hospital was collected reviewed successfully as sample size and entry was made in the data form specially design for this study. On an average 82% of participants righty knew the causative factors. In majority of participants knew that vaccine is available.
Conclusion: This study demonstrates awareness about risk factors of hepatitis B and c among people is persuasive. There is still need to educate people regarding some superstitions and environmental factors.
References
2. "Hepatitis C FAQs for Health Professionals'". CDC. January 8, 2016.Archived from theoriginal on 21 January 2016. Retrieved 4 February 2016
3. Maheshwari, A; Thuluvath, PJ (February 2010). "Management of acute hepatitis Clinics in Liver Disease. 14 (1): 169-76, C". doi:10.1016/j.cld.2009.11.007. PMID 20123448. X.
4. "Hepatitis C Fact sheet N°164". WHO. July 2015. Archived from the original on 31 January 2016Retrieved 4 February 2016
5. "Hepatitis B Fact sheet N°204", who.int. July 2014. Archived from the original on 9 November 2014. Retrieved 4 November 2014.
6. clinicopathologic foundations of medicine; [includes access to online text, cases, images, and audio review questions!] (5. ed.). Philadelphia [u.a.]: WoltersKluwer/Lippincott Williams & Wilkins. p. 638. ISBN9780781795166. Archived from the original on 28 September 2015.
7. "Hepatitis B FAQs for the Public – Transmission". U.S. Centers for Disease Control and Prevention (CDC). Archived from the original on 11 December 2011. Retrieved 29 November 2011.
8. Chang MH (June 2007). "Hepatitis B virus infection", Semin Fetal Neonatal Med. 12 (3): 160-167. doi:10.1016/j.siny.2007.01.013. PMID 17336170.
9. wiliams R (2006). "Global challenges in liver disease". Hepatologv. 44 (3): 521-526. doi:10.1002/hep.21347. PMID 16941687.
10. Fayyaz KM, Ali S, Khan AA, Shafique M, Khan MA, Majeed S, Butt AS. Henatitis B carriers; diagnosIS among volunteer blood donor students at Oid-i-Azam medical college Bahawalpur. Professional Med J. 2002:9:186-90. [Google Scholar)
11. (Bangash MH, Bangash TH, Alam S. Prevalance of hepatitis B and hepatatis C among healthy blood donors at Kurram agency. J Postgrad Med Inst. 2009;23:140-5. [Google Scholar])
12. ncbi.nlm.nih.gov/pmc/articles/PMC53549/#B6
13. Kwak MS, Kim YJ. Occult hepatitis B virus infection. World J Hepatol.2014; 6(12):860-864.. Doi:10.4254/wjh.v6.i12.860
14. ncbi.nlm.nih.gov/pmc/articles/PMC1194825/
15. Esteban J I, Esteban R, Viladomiu L et al. Hepatitis C virus antibodies among risk group in Spain lancet 1989:
16. Mortimer PP, Cohen BJ, Lotton PA et al. Hepatitis C virus antibody. Lancet 1989;10:345-5.
17. Teddel RS, Gilson RJC, Brigge M, et al. Hepatitis C virus: evidence for sexual transmission. BJM 1991; 302:1299-1302
18. jpma.org.pk/article-details/358?article-id=358